Skip to main content
Browse by:

The Investigational New Drug (IND) Workshop

Event Image
Tuesday, November 19, 2019
9:00 am - 12:00 pm
Rachel Johnson, PhD, RAC and Daniel Tonkin, PhD, RAC

Define an investigational drug, including off-label use of FDA approved drugs. Provide guidance on determining when the IND regulations apply to research studies.
Discuss the preparation and submission of IND applications to FDA.
Review maintenance and safety reporting requirements.
Encourage participant discussion of case scenarios.

Contact: Susan Nagorski